Top 10 Stocks in the S&P 500 by Index Weight Right Now
In this piece, we will take a look at the top ten stocks in the S&P 500 by index weight right now.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Impax Asset Management Ian Simm | 27,888 | $21,695,748 | -8% | 0.08% |
| 2. | HealthInvest Partners AB Anders Hallberg And Carl Bennet | 20,778 | $16,164,453 | +32% | 9.83% |
| 3. | McKinley Capital Management Robert B. Gillam | 18,654 | $14,512,194 | +11% | 1.74% |
| 4. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 13,555 | $10,545,248 | 0.92% | |
| 5. | Lee Munder Capital Group Lee Munder | 11,479 | $8,930,203 | -9% | 0.52% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $753.60 | 750 | Officer | 7,880 | 2024-03-11 | Filing | |
| $793.08 | 600 | 98,898,810 | 2024-02-16 | Filing | ||
| $792.05 | 600 | 98,899,410 | 2024-02-16 | Filing | ||
| $791.19 | 1,386 | 98,900,010 | 2024-02-16 | Filing | ||
| $790.23 | 3,603 | 98,901,396 | 2024-02-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 99,768,810 | $58,157,234,725 | 100% | |
| 2. | 71,611,201 | $41,743,601,288 | 0.91% | |
| 3. | 64,366,433 | $37,520,480,985 | 0.95% | |
| 4. | 33,787,327 | $19,695,308,655 | 0.95% | |
| 5. | 32,845,420 | $19,146,252,327 | 1.47% |
News See All
Eli Lilly and Company (NYSE:LLY) Q1 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q1 2024 Earnings Call. At this time all participants are in a listen-only mode.
30 Most Miserable Countries in the World
In this article, we shall discuss the 30 most miserable countries in the world.
Goldman Sachs' Top 15 Stock Picks for 2024
In this article, we'll take a look into Goldman Sachs' top 15 stock picks for 2024.
5 Best Growth Stocks To Invest In For the Next 5 Years
In this article, we discuss the 5 best growth stocks to invest in for the next 5 years.
20 Fastest Growing Health Tech Companies in the World
In this article, we will be taking a look at the 20 fastest growing health tech companies in the world.
14 Dividend Growth Stocks with Highest Growth Rates
In this article, we discuss 14 dividend growth stocks with highest growth rates.
Eli Lilly and Company (LLY) Rose due to Robust Q4 Sales
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.
11 Hot Growth Stocks To Buy Right Now
In this article, we discuss the 11 hot growth stocks to buy now.
13 Best Low Volatility Stocks to Buy According to Hedge Funds
In this article, we discuss the 13 best low volatility stocks to buy according to hedge funds.